Publicação
Gerresheimer equity research report - Part 2
| Resumo: | This report is part of a comprehensive equity research report on Gerresheimer AG, a company specializing in pharmaceutical packaging and drug delivery devices. This part of the report examines the company's current financial performance over the last five years. The report also forecasts future sales and estimates total sales of €3,901m in 2030.The report also analyses margin trends with a view to future profitability. In addition, a forecast of various balance sheet items such as property, plant and equipment, net working capital and intangible assets is provided. This is followed by a derivation of the future cash flows and the capital structure to determine the leverage ratio. The report calculates the cost of capital and uses the adjusted present value method to estimate the enterprise value (€ 6,380 million) and target share price (€ 148.14). The report concludes with a sensitivity analysis using the Monte Carlo simulation. |
|---|---|
| Autores principais: | Becker, Paul |
| Assunto: | Equity research Gerresheimer ag Medtech Packaging Company valuation |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | This report is part of a comprehensive equity research report on Gerresheimer AG, a company specializing in pharmaceutical packaging and drug delivery devices. This part of the report examines the company's current financial performance over the last five years. The report also forecasts future sales and estimates total sales of €3,901m in 2030.The report also analyses margin trends with a view to future profitability. In addition, a forecast of various balance sheet items such as property, plant and equipment, net working capital and intangible assets is provided. This is followed by a derivation of the future cash flows and the capital structure to determine the leverage ratio. The report calculates the cost of capital and uses the adjusted present value method to estimate the enterprise value (€ 6,380 million) and target share price (€ 148.14). The report concludes with a sensitivity analysis using the Monte Carlo simulation. |
|---|